Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xortx Therapeutics Inc (XRX.CN)

Xortx Therapeutics Inc (XRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 41,297
  • Shares Outstanding, K 12,291
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,285 K
  • 60-Month Beta 0.40
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 12.44
Trade XRX.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.35
  • Most Recent Earnings $-0.02 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.070 +56.35%
on 10/21/21
7.900 -39.24%
on 10/05/21
-2.200 (-31.43%)
since 10/04/21
3-Month
2.040 +135.29%
on 08/05/21
10.200 -52.94%
on 09/08/21
+2.640 (+122.22%)
since 08/04/21
52-Week
1.140 +321.05%
on 12/11/20
10.200 -52.94%
on 09/08/21
+3.180 (+196.30%)
since 11/04/20

Most Recent Stories

More News
XORTX Therapeutics Announces Publication of Mt. Sinai Study of Hospitalized COVID-19 Patients

CALGARY, Alberta, Dec. 10, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRX.CN : 4.800 (unch)
XRTX.VN : 2.390 (-2.05%)
XRTX : 1.7600 (-0.11%)
XORTX Announces Research Coverage Initiated by A.G.P./Alliance Global Partners

CALGARY, Alberta, Dec. 09, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

XRX.CN : 4.800 (unch)
XRTX.VN : 2.390 (-2.05%)
XRTX : 1.7600 (-0.11%)
XORTX Therapeutics Announces Annual and Special Meeting of Shareholders

CALGARY, Alberta, Nov. 23, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (TSXV: XRTX | NASDAQ: XRTX), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTX.VN : 2.390 (-2.05%)
XRTX : 1.7600 (-0.11%)
XORTX Therapeutics Clarifies Halt of Trading in Canada and Timing for Commencement of Trading on TSX Venture Exchange

CALGARY, Alberta, Nov. 04, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (TSXV: XRTX | NASDAQ: XRTX), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTX : 1.7600 (-0.11%)
XORTX Therapeutics Receives Final Approval to List on the TSX Venture Exchange

CALGARY, Alberta, Nov. 02, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTX : 1.7600 (-0.11%)
XORTX Therapeutics Announces Closing of US$12 Million Public Offering

CALGARY, Alberta, Oct. 15, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX | NASDAQ: XRTX), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTX : 1.7600 (-0.11%)
XRTXF : 0.4387 (-1.50%)
XORTX Announces Results from Mount Sinai’s COVID-19 Clinical Study

Early, High Uric Acid is Independently Associated with Acute Kidney Injury and Mortality in COVID-19...

XRX.CN : 4.800 (unch)
XRTX : 1.7600 (-0.11%)
XRTXF : 0.4387 (-1.50%)
XORTX to Present at the LD Micro Main Event

Virtual Corporate Presentation – October 14, 2021 – 10 am ET...

XRX.CN : 4.800 (unch)
XRTX : 1.7600 (-0.11%)
XRTXF : 0.4387 (-1.50%)
XORTX Therapeutics Announces Pricing of US$12 Million Public Offering and Nasdaq Listing

CALGARY, Alberta, Oct. 13, 2021 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (CSE: XRX) (OTCQB: XRTXF), a pharmaceutical...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)
XORTX to Present at "Zoom With LD MICRO"

CALGARY, AB / ACCESSWIRE / March 16, 2021 / XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE:XRX) (OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat progressive...

XRX.CN : 4.800 (unch)
XRTXF : 0.4387 (-1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

XORTX Therapeutics Inc is focused on developing drug therapies for orphan disease like polycystic kidney disease, and treatment of health consequences caused by chronic high serum uric acid which include cardiovascular disease and diabetes.

See More

Key Turning Points

3rd Resistance Point 4.800
2nd Resistance Point 4.800
1st Resistance Point 4.800
Last Price 4.800
1st Support Level 4.800
2nd Support Level 4.800
3rd Support Level 4.800

See More

52-Week High 10.200
Fibonacci 61.8% 6.739
Fibonacci 50% 5.670
Last Price 4.800
Fibonacci 38.2% 4.601
52-Week Low 1.140

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar